Skip to main content

Cytarabine Injection

Last Updated: December 2, 2022
Status: Current

Products Affected - Description
    • Cytarabine solution for injection, Pfizer, 100 mg/mL, 20 mL preservative-free vial, 1 count, NDC 61703-0319-22
    • Cytarabine solution for injection, Pfizer, 20 mg/mL, 50 mL preservative-free vial, 1 count, NDC 61703-0303-46
Reason for the Shortage
    • Fresenius Kabi has cytarabine on shortage due to a manufacturing delay.
    • Meitheal Pharmaceuticals had cytarabine on shortage due to a manufacturing delay.
    • Mylan Institutional has discontinued cytarabine presentations.
    • Pfizer had cytarabine on shortage due to increased demand.
Available Products
    • Cytarabine solution for injection, Fresenius Kabi, 100 mg/mL, 20 mL preservative-free vial, 1 count, NDC 63323-0120-20
    • Cytarabine solution for injection, Meitheal Pharmaceuticals, 100 mg/mL, 20 mL preservative-free vial, 1 count, NDC 71288-0109-20
    • Cytarabine solution for injection, Pfizer, 20 mg/mL, 25 mL multiple dose vial, 1 count, NDC 61703-0304-36
    • Cytarabine solution for injection, Pfizer, 20 mg/mL, 5 mL preservative-free vial, 5 count, NDC 61703-0305-38

Estimated Resupply Dates

    • Pfizer has cytarabine 20 mg/mL 50 mL vials and 100 mg/mL 20 mL vials available in limited supply.

Updated

Updated December 2, 2022 by Michelle Wheeler, PharmD, Drug Information Specialist. Created November 1, 2021 by Stephen Andrews, PharmD, BCPS, CPPS, Drug Information Specialist. © 2022, Drug Information Service, University of Utah, Salt Lake City, UT.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.